
President Trump's executive order reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act is the most significant shift in federal cannabis drug policy in decades. For cannabis businesses that have spent years navigating hostile banking relationships, limited payment options, and punishing tax treatment under Section 280E, the development carries real weight. But for payments and merchant acquiring specifically, the near-term picture is more constrained than the headline suggests.
Schedule III status acknowledges that marijuana has recognized medical value and carries lower abuse potential than Schedule I substances. The most concrete financial benefit: cannabis businesses can now deduct ordinary business expenses for federal tax purposes — a meaningful improvement in profitability that has been denied under Section 280E.
What reclassification does not do is legalize cannabis for general commercial sale. Products sold in state-licensed dispensaries remain unlawful without FDA approval. Proceeds from those sales are still considered illicit under federal law. That legal reality is what keeps major financial institutions on the sidelines, and it is not resolved by a scheduling change alone.
The American Bankers Association has maintained a consistent position: without explicit legal safe harbor, most major banks will not serve cannabis businesses. That position has not changed with reclassification. The risk calculus for large institutions has not shifted enough — they remain exposed to federal enforcement risk, and the scheduling order does not provide the explicit protection that legislation like the SAFER Banking Act would.
Visa and Mastercard network rules prohibit transactions for controlled substances. Schedule III does not change that. Cannabis merchants cannot access traditional card rails until those networks affirmatively change their policies, a change that requires the kind of legal certainty that does not yet exist.
The payments infrastructure that has developed around cannabis in the absence of mainstream options continues to expand. ACH-based payments — bank-to-bank electronic transfers that do not run on card network rails — have emerged as the primary compliant alternative.
The numbers reflect real momentum. An estimated 90% of dispensary transactions were handled in cash as recently as 2022. By 2025, ACH and PIN-debit options had begun cutting into that share. Industry analysts project that nearly 42% of cannabis transaction volume could move over ACH and real-time payment rails in 2026, up from roughly 28% in 2025.
ACH carries structural advantages in this context: transactions are traceable and auditable, fraud and chargeback rates are lower than card-based alternatives, and processing costs typically run around 2% compared to 3-5% or more for high-risk card processing. Modern pay-by-bank integrations have also addressed the friction problem, allowing customers to link bank accounts via QR code at the point of sale in seconds.
Reclassification signals that the market is moving toward legitimacy, but today's operational constraints still apply. Cannabis businesses need payment infrastructure built on compliant ACH and direct bank solutions — not workarounds or misclassified debit schemes that have drawn enforcement action in the past.
The compliance documentation burden has not lessened. Banking relationships in this sector still require enhanced due diligence, FinCEN reporting, and demonstrated operational compliance. Businesses that have invested in that infrastructure are better positioned as more regional banks begin exploring the space. Those operating without it will continue to face access problems regardless of the scheduling change.
The SAFER Banking Act remains the legislative development that would most materially change this picture. Until it passes or federal legalization occurs, the payments market for cannabis will continue to innovate within tight constraints.
Contact Qredible today to learn how our quality management solutions help cannabis businesses build the compliance documentation infrastructure, maintain operational transparency, and demonstrate the regulatory adherence that financial partners require to establish and sustain banking and payment processing relationships in this market.
Cannabis just moved to Schedule III — but if you're waiting for your bank or payment processor to change their policy, the legal safe harbor that would actually move the needle still hasn't arrived.